Loading...
Loncar China BioPharma ETF
CHNA•NASDAQ
Financial Services
Asset Management
$13.53
$-0.01(-0.07%)
Loncar China BioPharma ETF (CHNA) Company Profile & Overview
Explore Loncar China BioPharma ETF’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Loncar China BioPharma ETF (CHNA) Company Profile & Overview
The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.
SectorFinancial Services
IndustryAsset Management
Contact Information
DE
Company Facts
IPO DateAug 15, 2018
CountryUS